Citation
Kushner, Joseph, et al. "A Quality-by-design Study for an Immediate-release Tablet Platform: Examining the Relative Impact of Active Pharmaceutical Ingredient Properties, Processing Methods, and Excipient Variability On Drug Product Quality Attributes." Journal of Pharmaceutical Sciences, vol. 103, no. 2, 2014, pp. 527-38.
Kushner J, Langdon BA, Hicks I, et al. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes. J Pharm Sci. 2014;103(2):527-38.
Kushner, J., Langdon, B. A., Hicks, I., Song, D., Li, F., Kathiria, L., Kane, A., Ranade, G., & Agarwal, K. (2014). A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes. Journal of Pharmaceutical Sciences, 103(2), 527-38. https://doi.org/10.1002/jps.23810
Kushner J, et al. A Quality-by-design Study for an Immediate-release Tablet Platform: Examining the Relative Impact of Active Pharmaceutical Ingredient Properties, Processing Methods, and Excipient Variability On Drug Product Quality Attributes. J Pharm Sci. 2014;103(2):527-38. PubMed PMID: 24375069.
TY - JOUR
T1 - A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
AU - Kushner,Joseph,
AU - Langdon,Beth A,
AU - Hicks,Ian,
AU - Song,Daniel,
AU - Li,Fasheng,
AU - Kathiria,Lalji,
AU - Kane,Anil,
AU - Ranade,Gautam,
AU - Agarwal,Kam,
Y1 - 2013/12/20/
PY - 2013/05/31/received
PY - 2013/10/22/revised
PY - 2013/10/29/accepted
PY - 2013/12/31/entrez
PY - 2014/1/1/pubmed
PY - 2014/11/6/medline
KW - content uniformity
KW - excipients
KW - factorial design
KW - formulation
KW - hardness
KW - oral drug delivery
KW - quality by design (QBD)
KW - solid dosage form
KW - tableting
SP - 527
EP - 38
JF - Journal of pharmaceutical sciences
JO - J Pharm Sci
VL - 103
IS - 2
N2 - The impact of filler-lubricant particle size ratio variation (3.4-41.6) on the attributes of an immediate-release tablet was compared with the impacts of the manufacturing method used (direct compression or dry granulation) and drug loading (1%, 5%, and 25%), particle size (D[4,3]: 8-114 μm), and drug type (theophylline or ibuprofen). All batches were successfully manufactured, except for direct compression of 25% drug loading of 8 μm (D[4,3]) drug, which exhibited very poor flow properties. All manufactured tablets possessed adequate quality attributes: tablet weight uniformity <4% RSD, tablet potency: 94%-105%, content uniformity <6% RSD, acceptance value ≤ 15, solid fraction: 0.82-0.86, tensile strength >1 MPa, friability ≤ 0.2% weight loss, and disintegration time < 4 min. The filler-lubricant particle size ratio exhibited the greatest impact on blend and granulation particle size and granulation flow, whereas drug property variation dominated blend flow, ribbon solid fraction, and tablet quality attributes. Although statistically significant effects were observed, the results of this study suggest that the manufacturability and performance of this immediate-release tablet formulation is robust to a broad range of variation in drug properties, both within-grade and extra-grade excipient particle size variations, and the choice of manufacturing method.
SN - 1520-6017
UR - https://www.unboundmedicine.com/medline/citation/24375069/A_quality_by_design_study_for_an_immediate_release_tablet_platform:_examining_the_relative_impact_of_active_pharmaceutical_ingredient_properties_processing_methods_and_excipient_variability_on_drug_product_quality_attributes_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0022-3549(15)30707-3
DB - PRIME
DP - Unbound Medicine
ER -